Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This is the result of rapidly increasing demand in the Diabetes and Obesity Glucagon-like Peptide 1 (GLP-1) agonist medications market, and comes off the back of multiple, long-term, multiyear contracts totaling ~3bn, with potential upsides
Mounjaro is targeted at managing type 2 diabetes, while Zepbound addresses chronic weight management in individuals with obesity or those overweight with associated health conditions like high blood pressure or high cholesterol
Mechanism of Action Tirzepatide works by mimicking the activity of two hormones: GLP-1: Helps regulate blood sugar, slows gastric emptying, and increases feelings of fullness
Additionally, this subtype has been associated with enhanced mitochondrial function [20, 22]
US$ 20.48
US$ 24.28
US$ 21.98
